Live feed
·
INSIDERFilingvia Quantisnow
First Tracks Biotherapeutics Inc. logo

Director Fenton Dennis M converted options into 6,030 shares, increasing direct ownership by 121% to 10,995 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
First Tracks Biotherapeutics Inc. logo
TRAX
First Tracks Biotherapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for TRAX

Follow TRAX and get a push notification the moment its next story breaks.

Full TRAX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TRAX (First Tracks Biotherapeutics Inc.) and more on Quantisnow.